COVID19 Vaccine Latest Updates: The third phase of testing of indigenous vaccine covaxin (COVAXIN) against Covid-19 will begin soon in a private hospital in Bhubaneswar. Dr. E. Venkata Rao, Professor in the Department of Community Medicine at the Institute of Medical Sciences and SUM Hospital and Chief Monitoring Officer in the trial of covariance, says that the work of finding a suitable vaccine for Covid-19 is nearing the final stage. The Indian Council of Medical Research (ICMR) has approved 21 medical institutes of the country, including IMS and SUM Hospitals, for the Phase III trial.
Dr. Rao said that the Central Pharmaceutical Standards Control Institute (CDSCO) has received approval to start the Phase III trial for the indigenous vaccine COVAXIN being developed by ICMR and Bharat Biotech. After the first and second phase of testing, now this phase will be studied involving thousands of people.
Those older than 18 years will be included
The head of Preventive and Medical Diagnostic Testing Unit (PTCTU), Dr. Rao said that the age limit etc. will be relaxed during this phase. In contrast to the earlier steps, half of the people will be given cocaine. Health workers will also be included in this. Rao said that those over the age of 18 will be included in the test.
AstraZeneca’s another big success
On the other hand, AstraZeneca has got a great success. The company’s vaccine candidate has also been successful in triggering effective immune response against the novel coronavirus in the elderly. According to a Reuters report, a spokesperson for AstraZeneca has stated that the immunogenicity response to the vaccine candidate has remained the same among the elderly and young. However, reactogenicity was slightly lower in the elderly. These results are further strengthening the evidence for the safety and immunogenicity of AstraZeneca’s covid 19 vaccine candidate AZD1222. AstraZeneca, along with Oxford University, is developing the Covid 19 vaccine. The elderly are at greater risk of death from coronavirus as the immune system weakens with age. In such a situation, the new results of the AstraZeneca vaccine are positive news.
#COVID19 #Vaccine #Updates #COVAXIN #Phase #III #Trial #Bhubaneshwar #start #AstraZeneca #Vaccine #Effective #Elderly